Previous Article | Next Article 
Journal of Clinical Microbiology, August 2000, p. 3004-3009, Vol. 38, No. 8
0095-1137/00/$04.00+0
Molecular Epidemiology of Metronidazole Resistance
in a Population of Trichomonas vaginalis Clinical
Isolates
Lauren J.
Snipes,1,2
Pascale M.
Gamard,1
Elizabeth M.
Narcisi,1
C. Ben
Beard,3
Tovi
Lehmann,3 and
W. Evan
Secor1,*
Immunology Branch1 and
Entomology Branch,3 Division of
Parasitic Diseases, National Center for Infectious Diseases, Centers
for Disease Control and Prevention, Public Health Service, U.S.
Department of Health and Human Services, Atlanta, and
Department of Cellular Biology, University of Georgia,
Athens,2 Georgia
Received 13 January 2000/Returned for modification 25 April
2000/Accepted 30 May 2000
 |
ABSTRACT |
Trichomonas vaginalis, the causative agent for human
trichomoniasis, is a problematic sexually transmitted disease mainly in
women, where it may be asymptomatic or cause severe vaginitis and
cervicitis. Despite its high prevalence, the genetic variability and
drug resistance characteristics of this organism are poorly understood.
To address these issues, genetic analyses were performed on 109 clinical isolates using three approaches. First, two internal transcribed spacer (ITS) regions flanking the 5.8S subunit of the
ribosomal DNA gene were sequenced. The only variation was a point
mutation at nucleotide position 66 of the ITS1 region found in 16 isolates (14.7%). Second, the presence of a 5.5-kb double-stranded RNA
T. vaginalis virus (TVV) was assessed. TVV was detected in
55 isolates (50%). Finally, a phylogenetic analysis was performed
based on random amplified polymorphic DNA data. The resulting phylogeny
indicated at least two distinct lineages that correlate with the
presence of TVV. A band-sharing index indicating relatedness was
created for different groups of isolates. It demonstrated that isolates
harboring the virus are significantly more closely related to each
other than to the rest of the population, and it indicated a high level
of relatedness among isolates with in vitro metronidazole resistance.
This finding is consistent with the hypothesis that drug resistance to
T. vaginalis resulted from a single or very few mutational
events. Permutation tests and nonparametric analyses showed
associations between metronidazole resistance and phylogeny, the ITS
mutation, and TVV presence. These results suggest the existence of
genetic markers with clinical implications for T. vaginalis infections.
 |
INTRODUCTION |
Trichomonas vaginalis is
a protozoan parasite that infects the human urogenital tract and is the
causative agent of trichomoniasis, the most common nonviral sexually
transmitted disease (19). Infected individuals manifest a
wide range of symptoms, from an asymptomatic presentation to severe
sequelae. T. vaginalis infections have also been related to
complications during pregnancy, including premature rupture of
membranes (16), low birth weight, and preterm labor
(2). Another serious aspect of trichomoniasis is the association between T. vaginalis infection and an increased
risk of transmission of other sexually transmitted diseases, including human immunodeficiency virus (10).
Despite estimates of more than 170 million T. vaginalis
infections per year worldwide (27), very little is known
about the degree of T. vaginalis strain variation in patient
isolates and how these characteristics impact the clinical
manifestation of T. vaginalis infections. Most analyses of
isolate differences in T. vaginalis have been limited to
phenotypic observations, such as the level of drug resistance in vitro.
The few studies of genotypic variations have been limited to small
numbers of isolates, and most of the studies do not consider clinical
phenotypes. Broad studies of genetic polymorphisms can lead to the
distinction between strains with different phenotypes and could be
useful to link problematic infections to specific treatment strategies.
In one of the few studies involving genetic polymorphisms and clinical
phenotypes, Vanacova et al. (22) compared random amplified
polymorphic DNA (RAPD) data from 18 isolates of T. vaginalis to determine if this technique would be useful for strain typing of
clinical isolates. They found the RAPD data correlated with in vivo and
in vitro metronidazole resistance, geographic origin, and clinical
presentation. Their results suggest that RAPDs are powerful markers to
analyze genetic diversity in T. vaginalis and that study of
the T. vaginalis genome could help identify strains that are
associated with clinically significant data.
Ribosomal gene sequencing is another method commonly used to find
genetic polymorphisms between organisms. These genes are useful
primarily because of their conserved, ubiquitous nature. However,
internal transcribed spacer (ITS) regions are often more useful in
studies that involve closely related species. These regions exist
between the ribosomal genes and are found in all eukaryotic organisms,
but because they form no part of the functional ribosomal structure,
they are much less conserved than the actual genes. Even closely
related species can have ITS regions that vary widely in both
composition and length; therefore, ITS regions are ideal candidates for
intraspecies and intragenus comparisons (6).
An additional characteristic of T. vaginalis that may be
helpful in determining strain types or genetic relatedness is the presence of the Trichomonas vaginalis virus (TVV). TVV was
first identified in 1985 by Wang and Wang (23). It has no
known effect on the parasite but is found in approximately 50% of
clinical isolates (25). The genome of TVV consists of a
5.5-kb double-stranded RNA. Many other early diverging eukaryotes, such
as Giardia lamblia (15), Babesia spp.
(7), Leishmania spp. (26), and
Phytomonas spp. (13), also harbor similar
double-stranded RNA viruses. TVV has no known lytic cycle, and attempts
to infect isolates that are uninfected have been unsuccessful
(24). Therefore, it is probable that the virus is acquired
exclusively through vertical transmission, making its presence or
absence a useful genetic marker.
One of the most significant clinical traits of T. vaginalis
is resistance to metronidazole, the only drug currently licensed for
its treatment in the United States. Clinical resistance to metronidazole is associated with a patient's failure to clear infection following treatment with more than one standard course of
metronidazole. In the majority of cases, isolates from these patients
will also demonstrate metronidazole resistance in vitro under aerobic
conditions (9, 17; E. M. Narcisi, unpublished data).
This study examined the existence of metronidazole resistance as it
relates to the different genotypes found in a large population of
T. vaginalis isolates. The in vitro metronidazole resistance level was determined for each isolate. Differences in molecular characteristics were evaluated by assaying each isolate for TVV, sequencing the rRNA ITS region, and performing RAPD analysis. Statistical and phylogenetic analyses were performed to determine the
relationship of these characteristics in this large population of isolates.
 |
MATERIALS AND METHODS |
Isolates.
Isolates used in this study were obtained from
three different sources. The first group of isolates was obtained from
a single large urban teaching hospital (ATL isolates; n = 67). A vaginal swab from every woman who was admitted to the women's
urgent care center from March to May 1997 was cultured in TYM media
(3) with 10% heat-inactivated fetal bovine serum (pH 6.0).
Cultures were tested for T. vaginalis by examination of a
wet mount preparation. Patients were informed of the study, and
clinical data were collected on consenting patients whose cultures were
wet mount positive. The second group of isolates came from cultures
sent to the Centers for Disease Control and Prevention for the
metronidazole susceptibility testing service (MSA isolates;
n = 34). These isolates were collected between 1995 and
1998 by U.S. gynecologists from patients who did not respond to at
least two courses of standard metronidazole treatment. The isolates
were cryopreserved after no more than 30 days in culture. An additional
eight isolates that are commonly used in T. vaginalis
studies and have well-defined characteristics were also included in the
study as reference isolates. Personal identifiers were removed and the
source of isolates was kept anonymous to protect patient confidentiality.
Isolation of DNA.
Isolates of T. vaginalis were
grown in 50 ml of TYM media for 2 to 4 days until the culture
populations were in the log phase of growth. Cells for DNA extraction
were obtained by centrifugation of the 50-ml cultures at 430 × g for 20 min at 4°C. The resulting pellets were washed once
with phosphate-buffered saline (pH 7.4) and centrifuged again at
1,730 × g for 20 min at 4°C. Total nucleic acid was
extracted with the Isoquick nucleic acid extraction kit (ORCA Research,
Inc., Bothell, Wash.) according to the manufacturer's specifications.
The extracted nucleic acids were dissolved in RNase-free water. DNA
concentrations for each isolate were based on optical density readings
at a wavelength of 260 nm.
Trichomonas vaginalis virus.
All isolates used
in the study were screened for the presence of TVV by electrophoresis
of total nucleic acid extracts on an agarose gel stained with ethidium
bromide (EtBr) as described previously (23, 25). TVV
migrates at approximately 5.5 kb.
Metronidazole susceptibility assay.
An in vitro
metronidazole assay was performed for each isolate as originally
described by Meingässner et al. (14) and modified by
Narcisi and Secor (18). Briefly, cells were incubated in increasing levels of metronidazole (0.2 to 400 µg/ml) for 48 h under aerobic conditions. The minimum lethal concentration (MLC) was
determined to be the lowest concentration of metronidazole at which no
motile cells were found. Each assay was performed twice in triplicate
for each isolate tested, and dimethyl sulfoxide was used as a drug
carrier control.
PCR amplification of the ITS fragments.
The ITS region of
the ribosomal DNA (rDNA) was amplified through PCR using primers TVITSF
and TVITSR (ACCGCCCGTCGCTCCTACCGA and
CTCCGCTTAATGAGATGCTTC, respectively), which were designed from the conserved 3' end of the small ribosomal subunit gene and the
5' end of the large ribosomal subunit gene (1). Reactions were performed in a total volume of 50 µl, each reaction mixture containing 200 µmol of each deoxynucleoside triphosphate, 20 pmol of
each primer, 3 mM MgCl2, and 1.25 U of Taq
polymerase. Then, 200 mM of DNA template was added to each reaction
mixture. The reaction mixtures were overlaid with mineral oil, and
amplification was carried out in a Hybaid Omnigene thermocycler
(Vanguard International, Inc., Neptune, N.J.). The temperature profile
consisted of a 1-min denaturation step at 94°C followed by 40 cycles
at a melting temperature of 94°C for 1 min, an annealing temperature
of 54°C for 1 min, and an extension temperature of 72°C for 1 min.
After amplification, the PCR products were removed from mineral oil and
stored at
20°C. The presence of product was confirmed after EtBr
staining of a 1.5% agarose gel. The expected fragment migrated at 450 bp. Amplified products consisting of single, intense bands were then
purified from PCR primers using the Wizard DNA purification system
(Promega Corporation, Madison, Wis.).
Sequence of ITS fragments.
Automated sequencing was used to
determine the sequence of the ITS region for each isolate. The reaction
mixture consisted of 10 pmol of one primer, either TVITSF or TVITSR for
forward- and reverse-strand sequencing, respectively; 8 µl of the
ready reaction mixture (PE Applied Biosystems, Foster City, Calif.); and 13 µl of template. Reactions were carried out in a total reaction mixture volume of 20 µl on either a GeneAmp 9600 or a GeneAmp 2400 thermocycler (PE Applied Biosystems). Amplification consisted of 25 cycles of 96°C for 10 s, 50°C for 5 s, and 60°C for 4 min. Dye terminators were then removed from the sequencing PCR products using Centri-sep columns (Princeton Separations, Inc., Adelphia, N.J.).
The final sequencing was performed on the ABI 377 automated sequencer
(PE Applied Biosystems) using a 4% acrylamide gel.
Random amplified polymorphic DNA.
Each isolate was analyzed
with three different RAPD reactions. The three RAPD PCR mixtures
contained either 10 pmol of primer OPD3 (GTCGCCGTCA), 20 pmol of primer OPD5 (TGAGCGGACA), or 10 pmol each of primer
OPD1 (ACCGCGAAGG) and primer OPD2 (GGACCCAACC). The primers used were designed from Operon D kit primers (Operon Technologies, Alameda, Calif.). Each reaction mixture also contained 2.5 mM MgCl2, 250 µM of each deoxynucleoside
triphosphate, 1.25 U of Taq polymerase, and 25 ng of
template DNA. The samples were then overlaid with mineral oil and
amplified. Amplification consisted of 5 min at 94°C followed by 40 cycles of 94°C for 1 min, 36°C for 1 min, and 72°C for 2 min. A
final 15-min extension at 72°C was performed. Bands were separated on
a 0.75% agarose gel for 1.5 to 2 h at 108 V. The gel was then
stained in 300 ml of 1× Tris acetate-EDTA (TAE)-30 µl of EtBr for
15 min and destained in 1× TAE for 5 min. The banding pattern was
determined from observation of the gel on a UV transilluminator. The
presence or absence of each band was scored visually.
Statistical and epidemiological analyses.
A database
consisting of the molecular and phenotypic data for each isolate was
created in Epi Info 6 (Epidemiology Program Office, Centers for Disease
Control and Prevention, Atlanta, Ga.). Any significant associations
between characteristics, except the MLC values, were determined using
the Fisher exact test. A Mann-Whitney nonparametric test was used to
determine significant associations between the MLC values and other characteristics.
Phylogenetic analyses.
Phylogenetic analyses were performed
using RAPD data. A database was created consisting of every isolate and
its corresponding RAPD band pattern. To prevent the source of isolates
from confounding the results and to allow for population size
limitations of the analysis programs used, it was also necessary to
create smaller databases that included a portion of the total isolates
sampled. The three smaller databases used in these analyses consisted
of the following groupings: the 42 non-ATL isolates (34 MSA isolates and 8 reference isolates), all 67 ATL isolates, and a subpopulation of
29 ATL isolates for which patient clinical data were collected and
whose phenotypes represented those of all ATL isolates. The RAPDistance
program (version 1.04; Research School of Biological Sciences,
Australian National University, Canberra, Australia [http://life.anu.edu.au/molecular/software/rapd.html]) was then used
to determine pairwise distances between isolates for each smaller
grouping and for the entire set of isolates. For this calculation,
Pearson's phi coefficient (20), an algorithm that determines genetic distance based on shared traits (RAPD bands), was
used. Trees were designed using the neighbor-joining method based on
pairwise distances and are unrooted.
Treept, a program created by Flegr and Zaboj (
4), was used
to evaluate the neighbor-joining trees and their concordance
to
phenotypic traits based on a permutation tail probability (PTP)
test.
The program was used to create a total of 5,000 trees by
random
permutation. For each permutated tree, the average distance
between the
isolates sharing the same traits was calculated. The
distance between
isolates with the same traits in the neighbor-joining
tree was then
compared to the permutated trees' average distances.
The percentage of
random trees with a higher concordance to the
phenotype being analyzed
was determined. Phenotypes were considered
to be significantly
concordant with a neighbor-joining tree when
there was less than a 5%
chance of a random tree with a higher
concordance. Concordance with
metronidazole resistance was tested
in one of two ways. The 42 non-ATL
isolates were tested by assigning
each isolate with an MLC of less than
50 µg/ml a value of 1, those
with borderline resistance (MLC of 50 µg/ml) a value of 2, and
the resistant isolates (MLC > 50 µg/ml) a value of 3. Due to there
being no highly resistant ATL
strains and only a few borderline
strains, the exact MLC values were
used to determine the concordance
of the ATL isolates. Concordance with
TVV was tested by assigning
a "1" to isolates with the virus and a
"0" to isolates without
it. The ITS C66T mutation was tested by
assigning a "1" to the
isolates with the mutation and a "0" to
those without
it.
The final analysis examined the band data to determine if isolates that
share phenotypes have significantly more similar band
patterns than the
total set of isolates. A band-sharing index
was created for the group
of isolates being examined by determining
a band-shared value,
S, that is defined in the following formula:
Sxy = 2
nxy/(
nx +
ny) (
11), where
nxy
is the number of bands
shared by isolates
x and
y, and
nx and
ny represent the number
of bands present for
isolates
x and
y, respectively. The band-shared
value is an arbitrary number assigned to each group and has no
significance by itself. The significance of the band-shared index
was
evaluated by a PTP test that chooses a random sample, equal
in size to
the group being examined, from all 109 isolates. The
test was performed
2,000 times. If the original band-shared value
fell in the upper 95th
percentile of the permutated values, then
the group members were
considered to be significantly more closely
related to each other than
to the population as a
whole.
 |
RESULTS |
Prevalence of phenotypes.
Isolates with an in vitro aerobic
MLC of greater than or equal to 50 µg/ml are considered resistant to
metronidazole (12). Of the 67 ATL isolates, 6 (8.9%) showed
at least borderline aerobic resistance in vitro. The most resistant ATL
isolates had an MLC of 100 µg/ml. The MSA isolates showed a
resistance prevalence of 91% (31 of 34), but six of these isolates had
only borderline resistant MLCs (MLC = 50 µg/ml). The other 25 resistant MSA isolates had higher MLC values (100 µg/ml to >400
µg/ml). Of the eight non-ATL, non-MSA isolates, five had high levels
of metronidazole resistance (>400 µg/ml) and the other three were susceptible.
TVV was found in 50% of the total isolates (55 of 109). There was very
little difference between the frequency of positive
isolates in any of
the three groups. Table
1 summarizes the
distribution
of TVV among the three groups.
Clinical data were collected on 29 patients who did not show any signs
of concomitant vaginal infections. The patients were
scored on a
seven-point scale based on the number of symptoms
present. There were
no significant correlations between the virulence
score and TVV,
metronidazole resistance, rRNA sequence data, or
genetic relatedness
based on RAPD data (data not
shown).
Genetic polymorphisms.
Figure 1
is a diagram of the rDNA gene of T. vaginalis. The majority
of the isolates sequenced were identical to the consensus sequence
previously published by Katiyar et al. (8). However, 16 of
the 109 isolates (15%) had a point mutation at nucleotide position 66 of the ITS1 region in which a thymidine replaces a cytosine. The lower
portion of Fig. 1 shows the location of the C66T mutation.
Individually, 9% (6 of 67) of the ATL isolates, 26% (9 of 34) of the
MSA isolates, and 13% (1 of 8) of the other isolates were positive for
the C66T sequence. The 5.8S subunit and ITS2 region of all 109 isolates
were identical to each other and to the previously published sequences
(8).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of the rDNA gene of T. vaginalis. The rDNA gene of eukaryotic organisms is arranged in
tandem repeats. The ITS regions are transcribed with the gene and then
are removed before the ribosome is assembled. In the rDNA gene of
T. vaginalis, ITS1 begins at nucleotide position 1578 and
ends at nucleotide position 1658. A point mutation at the 66th position
of the ITS1 region (nucleotide position 1644 of the rDNA gene), in
which a cytosine is replaced by a thymidine, occurs in less than 15%
of the isolates.
|
|
To obtain RAPD data, five different primers were tested but only two,
OPD3 and OPD5, produced patterns consistent with detectable
isolate
differences on EtBr-stained agarose gels. The primers
that did not
produce patterns were combined to form multiplex
primer sets. One such
primer set was chosen using OPD1 and OPD2,
referred to as the OPD1-2
primer set. RAPD analysis was performed
on all isolates using the two
primers and the primer set. For
OPD3, bands at eight definitive
molecular weights were scored
as either present or absent for
each isolate. For the primers
OPD5 and OPD1-2, we used 9 and 12 bands,
respectively. The total
banding pattern of 29 bands was used as
character data in phylogenetic
analysis. Figure
2 is an example of a gel on which OPD3
PCR products
were run.

View larger version (109K):
[in this window]
[in a new window]
|
FIG. 2.
Representative agarose gel with OPD3 RAPD products. At
least two separate PCRs were performed for every isolate using each
primer. The gel shows the banding pattern of the PCR using OPD3 for 18 isolates. The lane on the far left was loaded with a 1-kb DNA ladder
(Promega).
|
|
Associations of TVV, ITS C66T mutation, and metronidazole
resistance.
Nonparametric analysis was used to examine the total
data set for relationships among phenotypes and molecular
characteristics. This was done to better understand the mechanisms
responsible for clinically significant phenotypes and to identify areas
where future research may help to uncover better treatment or
diagnostic methods. For example, as shown in Table
2, when the absence of TVV is compared
with the existence of resistance to metronidazole, considered among the
total population as an MLC of
50 µg/ml, there is a significant
inverse relationship (P = 0.0145). Figure 3A shows this relationship by comparing
the average MLC value among TVV-positive and TVV-negative isolates.
These results indicate that isolates not harboring TVV are more likely
to be resistant to metronidazole. There is also a significant inverse
relationship between the absence of TVV and the presence of the rDNA
ITS C66T mutation (P < 0.0001). In fact, all isolates
that harbored this point mutation were negative for the virus.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 3.
Average MLC for isolates with different characteristics.
(A) The average MLCs of isolates grouped based on the presence or
absence of TVV. (B) The average MLCs of isolates grouped based on the
presence or absence of the rDNA ITS C66T mutation. Isolates with MLC
values of >400 µg/ml were treated as 400 µg/ml.
|
|
A Mann-Whitney nonparametric analysis indicated that isolates with the
rDNA C66T ITS mutation had significantly higher MLC
values than those
isolates without the mutation (
P = 0.0012).
The
difference is clearly shown in Fig.
3B, which compares the
average MLC
value for isolates with and without the mutation.
As expected, a Fisher
exact test confirmed a significant relationship
between the rDNA ITS
C66T mutation and the presence of metronidazole
resistance
(
P = 0.0018).
Grouping of isolates by RAPD data.
The RAPD band data were
then used to characterize the isolates through phylogenetic analysis.
Phylogenetic trees were built using the RAPDistance program (see
above). The 34 MSA isolates fell into two major groups (Fig.
4). The upper half of the tree consists
of 18 isolates, all of which are negative for TVV. Also, all of the
isolates with the ITS C66T mutation are included in the upper half. The
lower branches consist of 14 isolates, all of which are positive for
TVV. The dendrogram shown in Fig. 5 demonstrates that the 29 ATL isolates for which we had clinical data
also fell into two major groups that correlated with the presence or
absence of TVV, with one exception. Isolate ATL 170 was TVV negative
but grouped with the TVV-positive isolates. Dendrograms constructed
from RAPD data for all 67 ATL isolates as well as the entire population
of 109 isolates demonstrated the same major groupings (results not
shown). These trees suggest that isolates with TVV are more closely
related to other isolates with TVV than to isolates without the virus.
This may be the result of a few, or possibly only one, genetic event
that occurred during the evolution of T. vaginalis in which
the virus was either lost or gained.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Dendrogram for MSA isolates based on RAPD data. The tree
was built by the neighbor-joining method. The distance matrix was
calculated with Pearson's phi coefficient based on RAPD data from
three primers (29 bands). Isolates negative for TVV (italicized) all
aggregated in the same (upper) branch, and TVV-positive isolates
grouped together in a separate branch. All isolates with the rDNA ITS
C66T mutation (underlined) also sorted into the main upper branch.
Branch lengths are drawn to scale based on genetic distances between
isolates.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 5.
Dendrogram for ATL isolates based on RAPD data. The tree
was built by the neighbor-joining method. The distance matrix was
calculated with Pearson's phi coefficient based on RAPD data from
three primers (29 bands). All isolates negative for TVV (italicized),
except ATL170, aggregated in one branch. All TVV-positive isolates
grouped together in the main lower branch. Isolates with the rDNA ITS
C66T mutation (underlined) were again associated with the TVV-negative
isolates in the main upper branch. Branch lengths are drawn to scale
based on genetic distances between isolates.
|
|
Concordance of traits.
The significant associations of
individual traits discussed previously were further supported by
additional analyses based on RAPD data using the Treept program. This
program tested for concordance between the trees shown in Fig. 4 and 5
and each phenotype. The trees consisting of 67 ATL isolates and 109 total isolates were not analyzed because of sample size limitations of
the Treept program. A PTP test was performed with Treept in which the
order of the isolates in each tree was compared to a phenotype of each isolate. A significant association indicated that there is a
relationship between the phenotype and the evolutionary assumptions
that the tree makes. In other words, this test was designed to
determine if a phenotype is significantly more likely to occur in
groups of isolates that are more closely related. The concordance of such phenotypes with a described phylogeny can lend support to the
phylogeny and can help to describe strains or lineages. The trees drawn
based on RAPD data showed a highly significant association with the
presence of TVV in both sets analyzed (P < 0.001).
Similarly, the dendrogram shown in Fig. 4 was significantly correlated
with the presence of the ITS C66T mutation (P = 0.0095). A comparison of the ATL dendrogram (Fig. 5) with the ITS
C66T mutation was not applicable because of the low incidence of the
mutation in this set of isolates. However, a significant association
was found between this tree and the MLC values of the isolates
(P = 0.0004).
Shared-band analysis.
A shared-band index that evaluated the
relatedness of isolates within a group confirmed many of the previously
described relationships. The RAPD band data were used to compute this
index. Table 3 shows the shared-band
index (S value) and its corresponding P value determined for several groups of isolates which share a particular trait. For example, isolates that harbor TVV have a significantly high
level of relatedness (P = 0.005). In other words, these
isolates share more bands than would be expected from a random grouping of 55 isolates in this total population. Isolates without TVV also
appear to be closely related although the relatedness is not
significant (P = 0.137). The only other group with a
significant level of relatedness is the group containing isolates with
metronidazole resistance (P = 0.003). This result
indicates that drug-resistant isolates have genomes that are more
similar to each other than they are to the group as a whole, suggesting
that they probably derived from a common ancestor. There also appears
to be a high level of relatedness among the ATL isolates and among the
isolates with the ITS C66T mutation, although the P values
do not achieve significance (P = 0.095 and 0.065, respectively).
 |
DISCUSSION |
RAPD trees were useful in the detection of evolutionary
relationships among T. vaginalis isolates with similar
molecular and phenotypic traits. This was demonstrated by the
correlation of all trees with the presence of TVV. Since there is no
known lytic cycle for TVV, it is unlikely that isolates acquire the
virus through horizontal transmission (24). Rather, the
inheritance of the virus from a parent strain to its progeny is the
most probable, and possibly the only, mode of transmission. The virus
can thus be a useful molecular marker for T. vaginalis. It
has been postulated that molecular markers correlating with
phylogenetic trees can be useful in lending support to the predicted
evolutionary relationships (21). Therefore, the nonrandom
association of TVV and the RAPD band patterns, two unrelated genotypic
characteristics, lends further support to the accuracy of the
phylogenetic trees produced in this study. In Fig. 5, the
virus-negative isolate, ATL170, is located among the TVV-positive
group. It is possible that this isolate lost the virus relatively
recently. It would therefore remain closely related to isolates
harboring the virus. This theory is supported by the observation of
isolates that have lost the virus after prolonged cultivation in vitro
(25).
The division of the trees into two distinct lineages
corresponding with the presence or absence of TVV (Fig. 4 and 5) is
further supported by the shared-band analysis for the TVV-positive
population, indicating that the isolates harboring the virus are more
closely related to each other than to TVV-negative isolates. This may suggest that a single predecessor of the TVV-positive isolates acquired
the virus or that the virus was lost multiple times from the
predecessors of the TVV-negative isolates. We also investigated the
possibility that this correlation could have resulted from the
amplification of the viral genome by the RAPD primers. However, there
was no evidence to suggest that viral genome amplification occurred
(data not shown).
The most interesting finding of this study is the association between
relatedness of metronidazole-resistant isolates based on RAPD data.
These results suggest that the development of resistant isolates has
occurred in only a few rare instances. Our data are consistent with the
findings of Vanacova et al. (22), where in vitro and in vivo
metronidazole resistance correlated with phylogenies based on RAPD
patterns. Unlike the previous study, the RAPD data presented here did
not correlate with the geographic origin of the isolates (data not
shown). However, the isolates in this study were from different cities
in the same country, as opposed to those of Vanacova et al., who
studied isolates that originated on different continents
(22). Phylogenies from the study by Vanacova and colleagues
did not correlate with TVV, but it is possible that the small sample
size used prevented the finding of a significant association.
As with all studies using RAPD as a typing technique, care must be
taken in the analysis of the results. Because of the arbitrary nature
of the PCR priming used in this technique, there is the possibility
that amplification from different loci may comigrate on a gel or that
variations in template concentration may result in sporadic fragments.
To guard against this possibility, we evaluated the primers over a
range of template concentrations to ensure that the banding patterns
were consistent (data not shown). Also, the correlation between our
RAPD results and heritable genotypic and phenotypic traits (TVV and
metronidazole resistance, respectively) suggests that the relationships
between the various isolates based on the RAPD data are reliable.
The ITS region of rDNA is often used in intraspecies studies because
variation is often found there. However, the lack of ITS sequence
variation among the T. vaginalis isolates shown here suggests a high level of relatedness among the isolates and a relatively short period of time since the isolates have diverged. This
lack of variability in the rDNA ITS region is consistent with findings
by Gunderson et al., which suggested that trichomonad species diverged
from each other relatively recently (5).
This study was designed to investigate the genetic diversity of
T. vaginalis in relation to clinical phenotypes of a large collection of isolates. A number of correlations between molecular and
phenotypic traits have been identified. Isolates with TVV are
significantly more likely to be susceptible to metronidazole, whereas
isolates with the ITS C66T mutation are significantly less likely to
be susceptible. Perhaps the most interesting finding is the
evidence that metronidazole resistance exists in a closely related
group of isolates, indicating that only one or a very few mutations
have occurred which result in resistance. This suggests that it may be
possible to identify a marker for resistance that could lead to
improved treatment strategies.
 |
ACKNOWLEDGMENTS |
We acknowledge Hugo Moreno and the Women's Health Clinic at
Grady Memorial Hospital, Atlanta, Ga. We also thank Jarsov Flegr from
Charles University for his cooperation in using the Treept program.
Epidemiologic support was provided by George Schmid and Debbie Mosure,
and Virginia Secor provided editorial assistance.
This study was funded in part by a grant from the Office of Women's
Health, CDC, Atlanta, Ga.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Parasitic Diseases, Mailstop F-13, NCID/CDC, 4770 Buford Highway NE,
Atlanta, GA 30341-3724. Phone: (770) 488-4115. Fax: (770) 488-3115. E-mail: was4{at}cdc.gov.
 |
REFERENCES |
| 1.
|
Chakrabarti, D.,
J. B. Dame,
R. R. Gutell, and C. A. Yowell.
1992.
Characterization of the rDNA unit and sequence analysis of the small subunit rRNA and 5.8S rRNA genes from Tritrichomonas foetus.
Mol. Biochem. Parasitol.
52:75-84[CrossRef][Medline].
|
| 2.
|
Cotch, M. F.,
J. G. Pastorek,
R. P. Nugent,
S. L. Hillier,
R. S. Gibbs,
D. H. Martin,
D. A. Exchenbach,
R. Edelman,
C. Carey,
J. A. Regan,
M. A. Drohn,
M. A. Kebanoff,
A. Vijaya,
G. G. Rhoads, and the Vaginal Infections and Prematurity Study Group.
1997.
Trichomonas vaginalis associated with low birth weight and preterm delivery.
Sex. Transm. Dis.
24:1-8.
|
| 3.
|
Diamond, L. S.
1957.
The establishment of various trichomonads of animals and man in axenic cultures.
J. Parasitol.
43:488-490[Medline].
|
| 4.
|
Flegr, J., and P. Zaboj.
1998.
PTPT, the freeware program for permutation testing concordance between phylogeny and the distribution of phenetic traits.
Acta Soc. Zool. Bohem.
61:91-95.
|
| 5.
|
Gunderson, J.,
G. Hinkle,
D. Leipe,
H. G. Morrison,
S. K. Stickel,
D. A. Odelson,
J. A. Breznak,
T. A. Nerad,
M. Muller, and M. L. Sogin.
1995.
Phylogeny of trichomonads inferred from small-subunit rRNA sequences.
J. Eukaryot. Microbiol.
42:411-415[Medline].
|
| 6.
|
Hillis, D. M., and M. T. Dixon.
1991.
Ribosomal DNA: molecular evolution and phylogenetic inference.
Q. Rev. Biol.
66:411-453[CrossRef][Medline].
|
| 7.
|
Hotzel, I.,
R. Kabakoff, and L. S. Ozaki.
1995.
Small extrachromosomal nucleic acid segments in protozoan parasites.
Vet. Parasitol.
57:57-60[CrossRef][Medline].
|
| 8.
|
Katiyar, S. K.,
G. S. Visvesvara, and T. D. Edlind.
1995.
Comparisons of ribosomal RNA sequences from a mitochondrial protozoa: implications for processing, mRNA binding and paromomycin susceptibility.
Gene
152:27-33[CrossRef][Medline].
|
| 9.
|
Kulda, J.
1999.
Trichomonads, hydrogenosomes and drug resistance.
Int. J. Parasitol.
29:199-212[CrossRef][Medline].
|
| 10.
|
Laga, M.,
A. Manoka,
M. Kivuvu, et al.
1993.
Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.
AIDS
7:95-102[Medline].
|
| 11.
|
Lehman, T.,
N. J. Besansky,
W. A. Hawley,
T. G. Fahey,
L. Kamua, and F. H. Collins.
1997.
Microgeographic structure of Anopheles gambiae in western Kenya based on mtDNA and microsatellite loci.
Mol. Ecol.
6:243-253[CrossRef][Medline].
|
| 12.
|
Lossick, J. G.
1989.
Therapy of urogenital trichomoniasis, p. 324-341.
In
B. M. Honigberg (ed.), Trichomonads parasitic in man. Springer-Verlag, New York, N.Y.
|
| 13.
|
Marche, S.,
C. Roth,
S. K. Manohar,
M. Dollet, and T. Baltz.
1993.
RNA virus-like particles in pathogenic plant trypanosomatids.
Mol. Biochem. Parasitol.
57:261-268[CrossRef][Medline].
|
| 14.
|
Meingässner, J. G.,
L. Havelec, and H. Mieth.
1978.
Studies on strain sensitivity of Trichomonas vaginalis to metronidazole.
Br. J. Vener. Dis.
54:72-76[Medline].
|
| 15.
|
Miller, R. L.,
A. L. Wang, and C. C. Wang.
1988.
Purification and characterization of the Giardia lamblia double-stranded RNA virus.
Mol. Biochem. Parasitol.
28:189-196[CrossRef][Medline].
|
| 16.
|
Minkoff, H.,
A. N. Grunebaum,
R. H. Schwarz,
J. Feldman,
M. Cummings,
W. Crumbleholme,
L. Clark,
G. Pringle, and W. M. McCormack.
1984.
Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy.
Am. J. Obstet. Gynecol.
150:965-972[Medline].
|
| 17.
|
Muller, M.,
J. G. Lossick, and T. E. Gorrell.
1988.
In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.
Sex. Transm. Dis.
15:17-24[Medline].
|
| 18.
|
Narcisi, E. M., and W. E. Secor.
1996.
In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
Antimicrob. Agents Chemother.
40:1121-1125[Abstract].
|
| 19.
|
Petrin, D.,
K. Delgaty,
R. Bhatt, and G. Garber.
1998.
Clinical and microbiological aspects of Trichomonas vaginalis.
Clin. Microbiol. Rev.
11:300-317[Abstract/Free Full Text].
|
| 20.
|
Sokal, R. R., and P. H. A. Sneath.
1963.
Principles in numerical taxonomy, p. 134.
W. H. Freeman & Co., New York, N.Y.
|
| 21.
|
Tibayrenc, M.
1998.
Beyond strain typing and molecular epidemiology: integrated genetic epidemiology of infectious diseases.
Parasitol. Today
14:323-329.
|
| 22.
|
Vanacova, S.,
J. Tachezy,
J. Kulda, and J. Flegr.
1997.
Characterization of trichomonad species and strains by PCR fingerprinting.
J. Eukaryot. Microbiol.
44:545-552[Medline].
|
| 23.
|
Wang, A. L., and C. C. Wang.
1985.
A linear double-stranded RNA in Trichomonas vaginalis.
J. Biol. Chem.
260:3697-3702[Abstract/Free Full Text].
|
| 24.
|
Wang, A. L., and C. C. Wang.
1986.
The double-stranded RNA in Trichomonas vaginalis may originate from virus-like particles.
Proc. Natl. Acad. Sci. USA
83:7956-7960[Abstract/Free Full Text].
|
| 25.
|
Wang, A. L.,
C. C. Wang, and J. F. Alderete.
1987.
Trichomonas vaginalis phenotypic variation occurs only among trichomonads infected with the double-stranded RNA virus.
J. Exp. Med.
166:142-150[Abstract/Free Full Text].
|
| 26.
|
Widmer, G., and S. Dooley.
1995.
Phylogenetic analysis of Leishmania RNA virus and Leishmania suggests ancient virus-parasite association.
Nucleic Acids Res.
23:2300-2304[Abstract/Free Full Text].
|
| 27.
|
World Health Organization.
1995.
An overview of selected curable sexually transmitted diseases, p. 2-27.
In
World Health Organization (ed.), Global program on AIDS. World Health Organization, Geneva, Switzerland.
|
Journal of Clinical Microbiology, August 2000, p. 3004-3009, Vol. 38, No. 8
0095-1137/00/$04.00+0
This article has been cited by other articles:
-
Meade, J. C., de Mestral, J., Stiles, J. K., Secor, W. E., Finley, R. W., Cleary, J. D., Lushbaugh, W. B.
(2009). Genetic Diversity of Trichomonas vaginalis Clinical Isolates Determined by EcoRI Restriction Fragment Length Polymorphism of Heat-Shock Protein 70 Genes. Am J Trop Med Hyg
80: 245-251
[Abstract]
[Full Text]
-
Guenthner, P. C., Secor, W. E., Dezzutti, C. S.
(2005). Trichomonas vaginalis-Induced Epithelial Monolayer Disruption and Human Immunodeficiency Virus Type 1 (HIV-1) Replication: Implications for the Sexual Transmission of HIV-1. Infect. Immun.
73: 4155-4160
[Abstract]
[Full Text]
-
Weber, B, Mapeka, T M, Maahlo, M A, Hoosen, A A
(2003). Double stranded RNA virus in South African Trichomonas vaginalis isolates. J. Clin. Pathol.
56: 542-543
[Abstract]
[Full Text]